Uxin Limited Loss Form

See If You Qualify For Monetary Reward

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit.

Submit Transaction Detail Now (Optional)

- OR -

    This submission does not create an attorney-client relationship. If we believe that you might be an appropriate lead plaintiff, we will contact you to discuss whether to establish an attorney-client relationship.

    FAX: 212-363-7171

    Levi & Korsinsky announces the commencement of a securities action on behalf of investors who purchased or otherwise acquired American Depositary Shares of Uxin Limited (“Uxin”) (NASDAQ: UXIN) pursuant and/or traceable to the Company’s false and/or misleading registration statement and prospectus issued in connection with the Company’s June 27, 2018 initial public offering.

    The complaint alleges that the Registration Statement was materially false and misleading and omitted to state that: (1) the Company was likely to stop providing complementary services such as inspections to its customers; (2) instead, the Company would connect consumers to dealers who would provide such complementary services; (3) as a result, the Company’s 2B business would be materially impacted; and (4) as a result of the foregoing, Defendants’ statements in the Registration Statement regarding Uxin’s business, operations, and prospects, were materially false and/or misleading.

    If you suffered a loss in Uxin you have until April 12, 2019 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.